A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2022; you can also visit the original URL.
The file type is application/pdf
.
Circulating HDL and Non-HDL Associated Apolipoproteins and Breast Cancer Severity
2022
Journal of Clinical Medicine
Plasma lipids are carried within lipoproteins with various apolipoprotein content. This study evaluates the interest of measuring the apolipoproteins of circulating lipoproteins in breast cancer. Patients with early-stage breast cancer (n = 140) were included. Tumors differed by the expression of estrogen and progesterone receptor (HR− and HR+ for negative and positive expression) and the proliferation marker Ki-67 (≤20% or ≥30%). Apolipoprotein concentrations were determined in plasma, HDL and
doi:10.3390/jcm11051345
pmid:35268435
pmcid:PMC8911350
fatcat:2ni7qdffhvh4doukzqbm4i4ybi